top of page

Measuring Blood Biomarkers with Greater Sensitivity - Cathepsin B Assay Developed

An ultrasensitive biomarker assay for cathepsin B measurement in blood has been developed as a research tool. Cathepsin B is a lysosomal cysteine protease that is important to a wide variety of functions throughout the body. It is involved in broad spectrum of diseases, injury states, and infections including cancer, dementia, brain trauma, as well as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Accurate measurement of cathepsin B is often challenging to achieve within blood samples due to interference or “noise”. This newly developed assay for cathepsin B offers increased accuracy and little to no background, which may facilitate research and enhance diagnostic utility of cathepsin B as a blood biomarker.


These studies were originally published in American Chemical Society (ACS), Omega


“Single Molecule Assay for Ultrasensitive Detection of Cathepsin B in Human Blood”

by

Bharani Thangavelu* and Angela M. Boutté


To learn how our expertise in brain biomarkers can augment your research needs, visit Aries Biotech at https://www.ariesbiotechnologies.org.

 
 
 

Recent Posts

See All

Comments


Golden Gate Bridge

Contact Us

Thank you. Aries Biotech will respond shortly.

Aries Biotech Consulting
4440 Keller Avenue, Suite 140, Box 199, Oakland, CA 94605
E-mail:  ariesbiotech.consult@gmail.com
Office
/Msg Ph:  650-246-9476

 

Subscribe for News and Updates

Thanks for submitting!

Disclaimer - This site and services are solely affiliated with Aries Biotech.
Name and logo are protected by trademark (USPTO No. 5826  and No. 5827).

bottom of page